Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
LABORATORIO REIG JOFRE ( (ES:RJF) ) has shared an announcement.
REIG JOFRE has been awarded a 13 million euro grant from the CDTi as part of the European IPCEI Med4Cure project, aimed at boosting pharmaceutical innovation. This grant supports REIG JOFRE’s EMINTECH project, which focuses on tackling global health challenges such as antimicrobial resistance and rare diseases through advanced therapies and cutting-edge technologies, enhancing the company’s strategic alignment with European health objectives.
More about LABORATORIO REIG JOFRE
REIG JOFRE is a pharmaceutical company listed on the Spanish stock exchange, specializing in the development, production, distribution, and marketing of essential health solutions, ranging from preventive care to critical medical situations.
Average Trading Volume: 34,762
Technical Sentiment Signal: Buy
Current Market Cap: €243.5M
Learn more about RJF stock on TipRanks’ Stock Analysis page.